title: Cum hoc sed non propter hoc.
authors.affiliation: INSERM U1111, Université de Lyon, Lyon, France.
authors.forename: C-C
authors.initials: CC
authors.lastname: Chen
authors.affiliation: Hospices Civils de Lyon, Service de Transplantation, Néphrologie et Immunologie Clinique, Hôpital Edouard Herriot, Lyon, France.
authors.forename: E
authors.initials: E
authors.lastname: Pouliquen
authors.affiliation: Hôpitaux Universitaires de Strasbourg, Service d'Endocrinologie Diabète et Maladies Métaboliques, Pôle MIRNED, EA 7293 Fédération de Médecine Translationnelle de Strasbourg, Université de Strasbourg, Strasbourg, France.
authors.forename: L
authors.initials: L
authors.lastname: Kessler
authors.affiliation: INSERM U1111, Université de Lyon, Lyon, France.|Laboratoire d'Histocompatibilité, Etablissement Français du Sang, Lyon, France.
authors.forename: V
authors.initials: V
authors.lastname: Dubois
authors.affiliation: INSERM U1111, Université de Lyon, Lyon, France.|Hospices Civils de Lyon, Service de Transplantation, Néphrologie et Immunologie Clinique, Hôpital Edouard Herriot, Lyon, France.
authors.forename: O
authors.initials: O
authors.lastname: Thaunat
mesh_terms: D000917:Antibody Formation; D000961:Antilymphocyte Serum; D007515:Islets of Langerhans; D012307:Risk Factors; D014019:Tissue Donors
chemical_list: D000961:Antilymphocyte Serum
keywords: alloantibody; animal models; graft survival; islet transplantation; rejection: antibody-mediated (ABMR); translational research/science